2022 年的期刊文章 · 第 22 页

共 1481 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2022-03-06 到 2022-02-18。

按期刊、按主题看 →

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 页

Biometrics Clinical Trials Bayesian Methods · 发表于 2022-03-06

Bayesian Sample Size Determination Using Commensurate Priors to Leverage Preexperimental Data

Haiyan Zheng, Thomas Jaki, James M.S. Wason

摘要

This paper develops Bayesian sample size formulae for experiments comparing two groups, where relevant preexperimental information from multiple sources can be incorporated in a robust prior to support both the design and analysis. We use commensurate predictive priors for borrowing of information and further place Gamma mixture priors on the precisions to account for preliminary belief about the pairwise (in)commensurability between parameters that underpin the historical and new experiments. Averaged over the probability space of the new experimental data, appropriate sample sizes are found according to criteria that control certain aspects of the posterior distribution, such as the coverage probability or length of a defined density region. Our Bayesian methodology can be applied to circumstances that compare two normal means, proportions, or event times. When nuisance parameters (such as variance) in the new experiment are unknown, a prior distribution can further be specified based on preexperimental data. Exact solutions are available based on most of the criteria considered for Bayesian sample size determination, while a search procedure is described in cases for which there are no closed-form expressions. We illustrate the application of our sample size formulae in the design of clinical trials, where pretrial information is available to be leveraged. Hypothetical data examples, motivated by a rare-disease trial with an elicited expert prior opinion, and a comprehensive performance evaluation of the proposed methodology are presented.

Biometrics Latent Variables & Mixtures High-Dimensional · 发表于 2022-03-05

Feature Screening with Latent Responses

Congran Yu, Wenwen Guo, Xinyuan Song, Hengjian Cui

摘要

A novel feature screening method is proposed to examine the correlation between latent responses and potential predictors in ultrahigh-dimensional data analysis. First, a confirmatory factor analysis (CFA) model is used to characterize latent responses through multiple observed variables. The expectation-maximization algorithm is employed to estimate the parameters in the CFA model. Second, R-Vector (RV) correlation is used to measure the dependence between the multivariate latent responses and covariates of interest. Third, a feature screening procedure is proposed on the basis of an unbiased estimator of the RV coefficient. The sure screening property of the proposed screening procedure is established under certain mild conditions. Monte Carlo simulations are conducted to assess the finite-sample performance of the feature screening procedure. The proposed method is applied to an investigation of the relationship between psychological well-being and the human genome.

Biometrics Longitudinal Data Causal Inference · 发表于 2022-03-05

Evaluating Treatment Effects in Group Sequential Multivariate Longitudinal Studies with Covariate Adjustment

Neal O. Jeffries, James F. Troendle, Nancy L. Geller

摘要

Jeffries et al. (2018) investigated testing for a treatment difference in the setting of a randomized clinical trial with a single outcome measured longitudinally over a series of common follow-up times while adjusting for covariates. That paper examined the null hypothesis of no difference at any follow-up time versus the alternative of a difference for at least one follow-up time. We extend those results here by considering multivariate outcome measurements, where each individual outcome is examined at common follow-up times. We consider the case where there is interest in first testing for a treatment difference in a global function of the outcomes (e.g., weighted average or sum) with subsequent interest in examining the individual outcomes, should the global function show a treatment difference. Testing is conducted for each follow-up time and may be performed in the setting of a group sequential trial. Testing procedures are developed to determine follow-up times for which a global treatment difference exists and which individual combinations of outcome and follow-up time show evidence of a difference while controlling for multiplicity in outcomes, follow-up, and interim analyses. These approaches are examined in a study evaluating the effects of tissue plasminogen activator on longitudinally obtained stroke severity measurements.

JASA Latent Variables & Mixtures · 发表于 2022-03-03

Score Matching for Compositional Distributions

Janice L. Scealy, Andrew T. A. Wood

摘要

Compositional data are challenging to analyse due to the non-negativity and sum-to-one constraints on the sample space. With real data, it is often the case that many of the compositional components are highly right-skewed, with large numbers of zeros. Major limitations of currently available models for compositional data include one or more of the following: insufficient flexibility in terms of distributional shape; difficulty in accommodating zeros in the data in estimation; and lack of computational viability in moderate to high dimensions. In this article, we propose a new model, the polynomially tilted pairwise interaction (PPI) model, for analysing compositional data. Maximum likelihood estimation is difficult for the PPI model. Instead, we propose novel score matching estimators, which entails extending the score matching approach to Riemannian manifolds with boundary. These new estimators are available in closed form and simulation studies show that they perform well in practice. As our main application, we analyse real microbiome count data with fixed totals using a multinomial latent variable model with a PPI model for the latent variable distribution. We prove that, under certain conditions, the new score matching estimators are consistent for the parameters in the new multinomial latent variable model. *(abstract via OpenAlex)*

SMMR Clinical Trials Diagnostics & Prediction Bayesian Methods · 发表于 2022-03-03

CFO: Calibration-free odds design for phase I/II clinical trials

Huaqing Jin, Guosheng Yin

摘要

Recent revolution in oncology treatment has witnessed emergence and fast development of the targeted therapy and immunotherapy. In contrast to traditional cytotoxic agents, these types of treatment tend to be more tolerable and thus efficacy is of more concern. As a result, seamless phase I/II trials have gained enormous popularity, which aim to identify the optimal biological dose (OBD) rather than the maximum tolerated dose (MTD). To enhance the accuracy and robustness for identification of OBD, we develop a calibration-free odds (CFO) design. For toxicity monitoring, the CFO design casts the current dose in competition with its two neighboring doses to obtain an admissible set. For efficacy monitoring, CFO selects the dose that has the largest posterior probability to achieve the highest efficacy under the Bayesian paradigm. In contrast to most of the existing designs, the prominent merit of CFO is that its main dose-finding component is model-free and calibration-free, which can greatly ease the burden on artificial input of design parameters and thus enhance the robustness and objectivity of the design. Extensive simulation studies demonstrate that the CFO design strikes a good balance between efficiency and safety for MTD identification under phase I trials, and yields comparable or sometimes slightly better performance for OBD identification than the competing methods under phase I/II trials.

JRSSB High-Dimensional · 发表于 2022-03-02

Supervised Multivariate Learning with Simultaneous Feature Auto-Grouping and Dimension Reduction

Yiyuan She, Jiahui Shen, Chao Zhang

摘要

Modern high-dimensional methods often adopt the ‘bet on sparsity’ principle, while in supervised multivariate learning statisticians may face ‘dense’ problems with a large number of nonzero coefficients. This paper proposes a novel clustered reduced-rank learning (CRL) framework that imposes two joint matrix regularizations to automatically group the features in constructing predictive factors. CRL is more interpretable than low-rank modelling and relaxes the stringent sparsity assumption in variable selection. In this paper, new information-theoretical limits are presented to reveal the intrinsic cost of seeking for clusters, as well as the blessing from dimensionality in multivariate learning. Moreover, an efficient optimization algorithm is developed, which performs subspace learning and clustering with guaranteed convergence. The obtained fixed-point estimators, although not necessarily globally optimal, enjoy the desired statistical accuracy beyond the standard likelihood setup under some regularity conditions. Moreover, a new kind of information criterion, as well as its scale-free form, is proposed for cluster and rank selection, and has a rigorous theoretical support without assuming an infinite sample size. Extensive simulations and real-data experiments demonstrate the statistical accuracy and interpretability of the proposed method.

Biometrics Longitudinal Data Nonparametric & Semiparametric · 发表于 2022-03-01

A Time-Heterogeneous D-Vine Copula Model for Unbalanced and Unequally Spaced Longitudinal Data

Md Erfanul Hoque, Elif F. Acar, Mahmoud Torabi

摘要

In many longitudinal studies, the number and timing of measurements differ across study subjects. Statistical analysis of such data requires accounting for both the unbalanced study design and the unequal spacing of repeated measurements. This paper proposes a time-heterogeneous D-vine copula model that allows for time adjustment in the dependence structure of unequally spaced and potentially unbalanced longitudinal data. The proposed approach not only offers flexibility over its time-homogeneous counterparts but also allows for parsimonious model specifications at the tree or vine level for a given D-vine structure. It further provides a robust strategy to specify the joint distribution of non-Gaussian longitudinal data. The performance of the time-heterogeneous D-vine copula models are evaluated through simulation studies and by a real data application. Our findings suggest improved predictive performance of the proposed approach over the linear mixed-effects model and time-homogeneous D-vine copula model.

JASA Survival Analysis Longitudinal Data Diagnostics & Prediction · 发表于 2022-02-28

Time-to-Event Analysis with Unknown Time Origins via Longitudinal Biomarker Registration

Tianhao Wang, Sarah J. Ratcliffe, Wensheng Guo

摘要

In observational studies, the time origin of interest for time-to-event analysis is often unknown, such as the time of disease onset. Existing approaches to estimating the time origins are commonly built on extrapolating a parametric longitudinal model, which rely on rigid assumptions that can lead to biased inferences. In this paper, we introduce a flexible semiparametric curve registration model. It assumes the longitudinal trajectories follow a flexible common shape function with person-specific disease progression pattern characterized by a random curve registration function, which is further used to model the unknown time origin as a random start time. This random time is used as a link to jointly model the longitudinal and survival data where the unknown time origins are integrated out in the joint likelihood function, which facilitates unbiased and consistent estimation. Since the disease progression pattern naturally predicts time-to-event, we further propose a new functional survival model using the registration function as a predictor of the time-to-event. The asymptotic consistency and semiparametric efficiency of the proposed models are proved. Simulation studies and two real data applications demonstrate the effectiveness of this new approach. *(abstract via PubMed)*

JASA Other · 发表于 2022-02-28

Statistical Inference with Local Optima

Yen-Chi Chen

摘要

We study the statistical properties of an estimator derived by applying a gradient ascent method with multiple initializations to a multi-modal likelihood function. We derive the population quantity that is the target of this estimator and study the properties of confidence intervals (CIs) constructed from asymptotic normality and the bootstrap approach. In particular, we analyze the coverage deficiency due to finite number of random initializations. We also investigate the CIs by inverting the likelihood ratio test, the score test, and the Wald test, and we show that the resulting CIs may be very different. We propose a two-sample test procedure even when the MLE is intractable. In addition, we analyze the performance of the EM algorithm under random initializations and derive the coverage of a CI with a finite number of initializations. *(abstract via OpenAlex)*

SMMR Nonparametric & Semiparametric · 发表于 2022-02-28

Mid-quantile regression for discrete responses

Marco Geraci, Alessio Farcomeni

摘要

We develop quantile regression methods for discrete responses by extending Parzen’s definition of marginal mid-quantiles. As opposed to existing approaches, which are based on either jittering or latent constructs, we use interpolation and define the conditional mid-quantile function as the inverse of the conditional mid-distribution function. We propose a two-step estimator whereby, in the first step, conditional mid-probabilities are obtained nonparametrically and, in the second step, regression coefficients are estimated by solving an implicit equation. When constraining the quantile index to a data-driven admissible range, the second-step estimating equation has a least-squares type, closed-form solution. The proposed estimator is shown to be strongly consistent and asymptotically normal. A simulation study shows that our estimator performs satisfactorily and has an advantage over a competing alternative based on jittering. Our methods can be applied to a large variety of discrete responses, including binary, ordinal, and count variables. We show an application using data on prescription drugs in the United States and discuss two key findings. First, our analysis suggests a possible differential medical treatment that worsens the gender inequality among the most fragile segment of the population. Second, obesity is a strong driver of the number of prescription drugs and is stronger for more frequent medications users. The proposed methods are implemented in the R package Qtools. Supplemental materials for this article, including a brief R tutorial, are available as an online supplement.

JASA Causal Inference · 发表于 2022-02-28

Identifying Effects of Multiple Treatments in the Presence of Unmeasured Confounding

Wang Miao, Wenjie Hu, Elizabeth L. Ogburn, Xiao-Hua Zhou

摘要

Identification of treatment effects in the presence of unmeasured confounding is a persistent problem in the social, biological, and medical sciences. The problem of unmeasured confounding in settings with multiple treatments is most common in statistical genetics and bioinformatics settings, where researchers have developed many successful statistical strategies without engaging deeply with the causal aspects of the problem. Recently there have been a number of attempts to bridge the gap between these statistical approaches and causal inference, but these attempts have either been shown to be flawed or have relied on fully parametric assumptions. In this article, we propose two strategies for identifying and estimating causal effects of multiple treatments in the presence of unmeasured confounding. The auxiliary variables approach leverages variables that are not causally associated with the outcome; in the case of a univariate confounder, our method only requires one auxiliary variable, unlike existing instrumental variable methods that would require as many instruments as there are treatments. An alternative null treatments approach relies on the assumption that at least half of the confounded treatments have no causal effect on the outcome, but does not require a priori knowledge of which treatments are null. Our identification strategies do not impose parametric assumptions on the outcome model and do not rest on estimation of the confounder. This article extends and generalizes existing work on unmeasured confounding with a single treatment and models commonly used in bioinformatics. Supplementary materials for this article are available online. *(abstract via OpenAlex)*

JASA Networks & Graphs Latent Variables & Mixtures · 发表于 2022-02-28

Dynamic Stochastic Blockmodel Regression for Network Data: Application to International Militarized Conflicts

Santiago Olivella, Tyler Pratt, Kosuke Imai

摘要

The decision to engage in military conflict is shaped by many factors, including state- and dyad-level characteristics as well as the state’s membership in geopolitical coalitions. Supporters of the democratic peace theory, for example, hypothesize that the community of democratic states is less likely to wage war with each other. Such theories explain the ways in which nodal and dyadic characteristics affect the evolution of conflict patterns over time via their effects on group memberships. To test these arguments, we develop a dynamic model of network data by combining a hidden Markov model with a mixed-membership stochastic blockmodel that identifies latent groups underlying the network structure. Unlike existing models, we incorporate covariates that predict dynamic node memberships in latent groups as well as the direct formation of edges between dyads. While prior substantive research often assumes the decision to engage in international militarized conflict is independent across states and static over time, we demonstrate that conflict is driven by states’ evolving membership in geopolitical blocs. Our analysis of militarized disputes from 1816 to 2010 identifies two distinct blocs of democratic states, only one of which exhibits unusually low rates of conflict. Changes in monadic covariates like democracy shift states between coalitions, making some states more pacific but others more belligerent. Supplementary materials for this article are available online. *(abstract via OpenAlex)*

Biometrics Latent Variables & Mixtures Genetics & Omics Optimization & Learning Theory · 发表于 2022-02-27

Multisource Single-Cell Data Integration by MAW Barycenter for Gaussian Mixture Models

Lin Lin, Wei Shi, Jianbo Ye, Jia Li

摘要

One key challenge encountered in single-cell data clustering is to combine clustering results of data sets acquired from multiple sources. We propose to represent the clustering result of each data set by a Gaussian mixture model (GMM) and produce an integrated result based on the notion of Wasserstein barycenter. However, the precise barycenter of GMMs, a distribution on the same sample space, is computationally infeasible to solve. Importantly, the barycenter of GMMs may not be a GMM containing a reasonable number of components. We thus propose to use the minimized aggregated Wasserstein (MAW) distance to approximate the Wasserstein metric and develop a new algorithm for computing the barycenter of GMMs under MAW. Recent theoretical advances further justify using the MAW distance as an approximation for the Wasserstein metric between GMMs. We also prove that the MAW barycenter of GMMs has the same expectation as the Wasserstein barycenter. Our proposed algorithm for clustering integration scales well with the data dimension and the number of mixture components, with complexity independent of data size. We demonstrate that the new method achieves better clustering results on several single-cell RNA-seq data sets than some other popular methods.

SiM Missing Data & Measurement Error · 发表于 2022-02-27

Extending the susceptible‐exposed‐infected‐removed (SEIR) model to handle the false negative rate and symptom‐based administration of COVID‐19 diagnostic tests: SEIR‐fansy

Ritwik Bhaduri, Ritoban Kundu, Soumik Purkayastha, Michael Kleinsasser, Lauren J. Beesley, Bhramar Mukherjee, Jyotishka Datta

摘要

False negative rates of severe acute respiratory coronavirus 2 diagnostic tests, together with selection bias due to prioritized testing can result in inaccurate modeling of COVID‐19 transmission dynamics based on reported “case” counts. We propose an extension of the widely used Susceptible‐Exposed‐Infected‐Removed (SEIR) model that accounts for misclassification error and selection bias, and derive an analytic expression for the basic reproduction number as a function of false negative rates of the diagnostic tests and selection probabilities for getting tested. Analyzing data from the first two waves of the pandemic in India, we show that correcting for misclassification and selection leads to more accurate prediction in a test sample. We provide estimates of undetected infections and deaths between April 1, 2020 and August 31, 2021. At the end of the first wave in India, the estimated under‐reporting factor for cases was at 11.1 (95% CI: 10.7,11.5) and for deaths at 3.58 (95% CI: 3.5,3.66) as of February 1, 2021, while they change to 19.2 (95% CI: 17.9, 19.9) and 4.55 (95% CI: 4.32, 4.68) as of July 1, 2021. Equivalently, 9.0% (95% CI: 8.7%, 9.3%) and 5.2% (95% CI: 5.0%, 5.6%) of total estimated infections were reported on these two dates, while 27.9% (95% CI: 27.3%, 28.6%) and 22% (95% CI: 21.4%, 23.1%) of estimated total deaths were reported. Extensive simulation studies demonstrate the effect of misclassification and selection on estimation of and prediction of future infections. A R‐package SEIRfansy is developed for broader dissemination.

Biometrics Bayesian Methods High-Dimensional · 发表于 2022-02-27

Bayesian Interaction Selection Model for Multimodal Neuroimaging Data Analysis

Yize Zhao, Ben Wu, Jian Kang

摘要

Multimodality or multiconstruct data arise increasingly in functional neuroimaging studies to characterize brain activity under different cognitive states. Relying on those high-resolution imaging collections, it is of great interest to identify predictive imaging markers and intermodality interactions with respect to behavior outcomes. Currently, most of the existing variable selection models do not consider predictive effects from interactions, and the desired higher-order terms can only be included in the predictive mechanism following a two-step procedure, suffering from potential misspecification. In this paper, we propose a unified Bayesian prior model to simultaneously identify main effect features and intermodality interactions within the same inference platform in the presence of high-dimensional data. To accommodate the brain topological information and correlation between modalities, our prior is designed by compiling the intermediate selection status of sequential partitions in light of the data structure and brain anatomical architecture, so that we can improve posterior inference and enhance biological plausibility. Through extensive simulations, we show the superiority of our approach in main and interaction effects selection, and prediction under multimodality data. Applying the method to the Adolescent Brain Cognitive Development (ABCD) study, we characterize the brain functional underpinnings with respect to general cognitive ability under different memory load conditions.

Biometrics Missing Data & Measurement Error · 发表于 2022-02-26

Leveraging a Surrogate Outcome to Improve Inference on a Partially Missing Target Outcome

Zachary R. McCaw, Sheila M. Gaynor, Ryan Sun, Xihong Lin

摘要

Sample sizes vary substantially across tissues in the Genotype-Tissue Expression (GTEx) project, where considerably fewer samples are available from certain inaccessible tissues, such as the substantia nigra (SSN), than from accessible tissues, such as blood. This severely limits power for identifying tissue-specific expression quantitative trait loci (eQTL) in undersampled tissues. Here we propose Surrogate Phenotype Regression Analysis (Spray) for leveraging information from a correlated surrogate outcome (eg, expression in blood) to improve inference on a partially missing target outcome (eg, expression in SSN). Rather than regarding the surrogate outcome as a proxy for the target outcome, Spray jointly models the target and surrogate outcomes within a bivariate regression framework. Unobserved values of either outcome are treated as missing data. We describe and implement an expectation conditional maximization algorithm for performing estimation in the presence of bilateral outcome missingness. Spray estimates the same association parameter estimated by standard eQTL mapping and controls the type I error even when the target and surrogate outcomes are truly uncorrelated. We demonstrate analytically and empirically, using simulations and GTEx data, that in comparison with marginally modeling the target outcome, jointly modeling the target and surrogate outcomes increases estimation precision and improves power.

Biometrika Other · 发表于 2022-02-25

Optimal minimax random designs for weighted least squares estimators

D Azriel

摘要

Summary: This work studies an experimental design problem where the values of a predictor variable, denoted by $x$, are to be determined with the goal of estimating a function $m(x)$, which is observed with noise. A linear model is fitted to $m(x)$, but it is not assumed that the model is correctly specified. It follows that the quantity of interest is the best linear approximation of $m(x)$, which is denoted by $\ell(x)$. It is shown that in this framework the ordinary least squares estimator typically leads to an inconsistent estimation of $\ell(x)$, and rather weighted least squares should be considered. An asymptotic minimax criterion is formulated for this estimator, and a design that minimizes the criterion is constructed. An important feature of this problem is that the $x$ values should be random, rather than fixed. Otherwise, the minimax risk is infinite. It is shown that the optimal random minimax design is different from its deterministic counterpart, which was studied previously, and a simulation study indicates that it generally performs better when $m(x)$ is a quadratic or a cubic function. Another finding is that, when the variance of the noise goes to infinity, the random and deterministic minimax designs coincide. The results are illustrated for polynomial regression models and a generalization is given in the Supplementary Material.

Biometrika Machine Learning · 发表于 2022-02-25

Mean decrease accuracy for random forests: inconsistency, and a practical solution via the Sobol-MDA

Clément Bénard, Sébastien Da Veiga, Erwan Scornet

摘要

Summary: Variable importance measures are the main tools used to analyse the black-box mechanisms of random forests. Although the mean decrease accuracy is widely accepted as the most efficient variable importance measure for random forests, little is known about its statistical properties. In fact, the definition of mean decrease accuracy varies across the main random forest software. In this article, our objective is to rigorously analyse the behaviour of the main mean decrease accuracy implementations. Consequently, we mathematically formalize the various implemented mean decrease accuracy algorithms, and then establish their limits when the sample size increases. This asymptotic analysis reveals that these mean decrease accuracy versions differ as importance measures, since they converge towards different quantities. More importantly, we break down these limits into three components: the first two terms are related to Sobol indices, which are well-defined measures of a covariate contribution to the response variance, widely used in the sensitivity analysis field, as opposed to the third term, whose value increases with dependence within covariates. Thus, we theoretically demonstrate that the mean decrease accuracy does not target the right quantity to detect influential covariates in a dependent setting, a fact that has already been noticed experimentally. To address this issue, we define a new importance measure for random forests, the Sobol-mean decrease accuracy, which fixes the flaws of the original mean decrease accuracy, and consistently estimates the accuracy decrease of the forest retrained without a given covariate, but with an efficient computational cost. The Sobol-mean decrease accuracy empirically outperforms its competitors on both simulated and real data for variable selection.

Biometrika Other · 发表于 2022-02-24

Particle filter efficiency under limited communication

Deborshee Sen

摘要

Summary: Sequential Monte Carlo methods are typically not straightforward to implement on parallel architectures. This is because standard resampling schemes involve communication between all particles. The $$\alpha$$-sequential Monte Carlo method was proposed recently as a potential solution to this that limits communication between particles. This limited communication is controlled through a sequence of stochastic matrices known as $$\alpha$$ matrices. We study the influence of the communication structure on the convergence and stability properties of the resulting algorithms. In particular, we quantitatively show that the mixing properties of the $$\alpha$$ matrices play an important role in the stability properties of the algorithm. Moreover, we prove that one can ensure good mixing properties by using randomized communication structures where each particle only communicates with a few neighbouring particles. The resulting algorithms converge at the usual Monte Carlo rate. This leads to efficient versions of distributed sequential Monte Carlo.

Biometrika High-Dimensional Testing & Uncertainty · 发表于 2022-02-24

An approximate randomization test for the high-dimensional two-sample Behrens–Fisher problem under arbitrary covariances

Rui Wang, Wangli Xu

摘要

Summary: This paper is concerned with the problem of comparing the population means of two groups of independent observations. An approximate randomization test procedure based on the test statistic of Chen & Qin (2010) is proposed. The asymptotic behaviour of the test statistic, as well as the randomized statistic, is studied under weak conditions. In our theoretical framework, observations are not assumed to be identically distributed even within groups. No condition on the eigenstructure of the covariance matrices is imposed. Furthermore, the sample sizes of the two groups are allowed to be unbalanced. Under general conditions, all possible asymptotic distributions of the test statistic are obtained. We derive the asymptotic level and local power of the approximate randomization test procedure. Our theoretical results show that the proposed test procedure can adapt to all possible asymptotic distributions of the test statistic, always has the correct test level asymptotically and has good power behaviour. Our numerical experiments show that the proposed test procedure has favourable performance compared with several alternative test procedures.

SMMR Meta-Analysis & Data Integration Nonparametric & Semiparametric Networks & Graphs · 发表于 2022-02-24

A dose–effect network meta-analysis model with application in antidepressants using restricted cubic splines

Tasnim Hamza, Toshi A Furukawa, Nicola Orsini, Andrea Cipriani, Cynthia P Iglesias, Georgia Salanti

摘要

Network meta-analysis has been used to answer a range of clinical questions about the preferred intervention for a given condition. Although the effectiveness and safety of pharmacological agents depend on the dose administered, network meta-analysis applications typically ignore the role that drugs dosage plays in the results. This leads to more heterogeneity in the network. In this paper, we present a suite of network meta-analysis models that incorporate the dose–effect relationship using restricted cubic splines. We extend existing models into a dose–effect network meta-regression to account for study-level covariates and for groups of agents in a class-effect dose–effect network meta-analysis model. We apply our models to a network of aggregate data about the efficacy of 21 antidepressants and placebo for depression. We find that all antidepressants are more efficacious than placebo after a certain dose. Also, we identify the dose level at which each antidepressant's effect exceeds that of placebo and estimate the dose beyond which the effect of antidepressants no longer increases. When covariates were introduced to the model, we find that studies with small sample size tend to exaggerate antidepressants efficacy for several of the drugs. Our dose–effect network meta-analysis model with restricted cubic splines provides a flexible approach to modelling the dose–effect relationship in multiple interventions. Decision-makers can use our model to inform treatment choice.

SiM Econometrics & Economics · 发表于 2022-02-23

Two decades of statistical education collaboration in the global South: Lessons learned from an Ethiopian project and the way forward

Luc Duchateau, Paul Janssen

摘要

Worldwide, the need as well as the demand for statistical professionals with good theoretical background and practical skills is still increasing over the years, and the global South is not an exception to that. With support of the Flemish Interuniversity Council-University Development Collaboration (VLIR-UOS), the MSc program in Biostatistics at Hasselt University (Belgium) provides, since 1993, scholarships for students from the South. Every year a number of scholarships (at the moment 12 scholarships/year) are available for students from one of the 32 countries on the VLIR-UOS country list (https://www.vliruos.be/en/countries/96, from Africa (19), Asia (5), and Latin America (8)). The scholarships cover their stay in Belgium during the 2-year of study. We welcomed our first students in 1998, in the meantime approximately 300 VLIR-UOS scholars obtained their master degree in Biostatistics. Although the MSc program delivered a large number of skilled statisticians to universities, medical research and health institutes, and governmental organizations, the need to start or to reinforce in parallel master programs at the local level quickly became clear. The basic idea being that building capacity in the country itself is the most sustainable way. The arguments that support this idea include: it will avoid brain drain, it will lead to the training of many more students, and last but not least, it will provide the opportunity for lecturers working and teaching at academic institutions in the South to further strengthen their statistical knowledge and to get involved in teaching at the MSc level. A nice opportunity to develop such a South MSc program arose in Ethiopia when Ghent University started, in 2007, the long term VLIR-UOS Institutional University Cooperation (IUC) project at Jimma University, Ethiopia "Investigating the impact of the Gilgel Gibe dam: a multidisciplinary approach towards capacity building." The IUC project covered different research disciplines, including human medicine (eg, research on malaria) and (bio)statistics. Within the framework of the statistics project, a North-South collaboration team was set up to establish a MSc in Biostatistics at Jimma University. First, a curriculum was developed by the team and was accredited by the Ministry of Education, Ethiopia. At the time, no PhD holders were present among the academic staff members of the Department of Statistics at Jimma University, so the first objective of the collaboration was to involve selected staff members in PhD training, spending the academic year partly at Jimma and partly at Ghent or Hasselt University (sandwich scholarship system). This capacity building activity fitted neatly in the philosophy of the IUC project. At the same time each of these staff members was linked to a particular course of the MSc program in Biostatistics at Hasselt University. In this way, through a collaboration between the course instructor and the visitor from Jimma, several courses of the MSc program have been revised and adapted to fit the local needs at Jimma University. For each course, several end products were delivered: a syllabus together with slides, exams questions as well as practical examples using local data stemming from research related to the Gilgel Gibe project. In the first few years (2011-2015), courses were taught jointly (local and Belgian instructor) at Jimma University, with the objective that thereafter the responsibility would go entirely to the local person. The PhD program went very well, with eight academic staff members from Jimma University obtaining their PhD degree from three different Flemish universities (Hasselt University, Ghent University, and KU Leuven). The research topics of these PhDs were linked with the IUC research objectives. For instance, one PhD student investigated the effect of distance from a hydroelectric dam on malaria incidence in Ethiopia, 1 another PhD student worked for the infectious disease subproject and modeled aspects of HIV treatment in Ethiopia. 2 Unfortunately, none of the PhD holders stayed at Jimma University, with brain drain to South Africa, Europe, and the United States, which decapitated the MSc program in Biostatistics at Jimma University. The MSc program in Biostatistics at Jimma University still delivers MSc degrees, the jointly developed course material is still used, but the most important valuable asset, well trained local lecturers with a PhD degree, no longer supports the program. Given the large demand internationally for statisticians, the PhD holders had many options outside Ethiopia to shape their academic career and to improve their living conditions. Given the Statistics in Medicine. 2022;41:845-846. wileyonlinelibrary.com/journal/sim *(abstract via OpenAlex)*

SiM Other · 发表于 2022-02-23

Statistical advising: Professional development opportunities for the biostatistician

Marissa LeBlanc, Corina S. Rueegg, Nural Bekiroğlu, Tonya M. Esterhuizen, Morten W. Fagerland, Ragnhild S. Falk, Kathrine F. Frøslie, Erika Graf, Georg Heinze, Ulrike Held, René Holst, Theis Lange, Madhu Mazumdar, Ida H. Myrberg, Martin Posch, Jamie C. Sergeant, Werner Vach, Eric A. Vance, Harald Weedon‐Fekjær, Manuela Zucknick

摘要

Statistical advising: Professional development opportunities for the biostatistician *(abstract via OpenAlex)*

SiM Clinical Trials Latent Variables & Mixtures · 发表于 2022-02-23

Sample size estimation using a latent variable model for mixed outcome co‐primary, multiple primary and composite endpoints

Martina E. McMenamin, Jessica K. Barrett, Anna Berglind, James M. S. Wason

摘要

Mixed outcome endpoints that combine multiple continuous and discrete components are often employed as primary outcome measures in clinical trials. These may be in the form of co‐primary endpoints, which conclude effectiveness overall if an effect occurs in all of the components, or multiple primary endpoints, which require an effect in at least one of the components. Alternatively, they may be combined to form composite endpoints, which reduce the outcomes to a one‐dimensional endpoint. There are many advantages to joint modeling the individual outcomes, however in order to do this in practice we require techniques for sample size estimation. In this article we show how the latent variable model can be used to estimate the joint endpoints and propose hypotheses, power calculations and sample size estimation methods for each. We illustrate the techniques using a numerical example based on a four‐dimensional endpoint and find that the sample size required for the co‐primary endpoint is larger than that required for the individual endpoint with the smallest effect size. Conversely, the sample size required in the multiple primary case is similar to that needed for the outcome with the largest effect size. We show that the empirical power is achieved for each endpoint and that the FWER can be sufficiently controlled using a Bonferroni correction if the correlations between endpoints are less than 0.5. Otherwise, less conservative adjustments may be needed. We further illustrate empirically the efficiency gains that may be achieved in the composite endpoint setting.

SiM Clinical Trials Bayesian Methods Econometrics & Economics 讨论 / 评论 · 发表于 2022-02-23

Commentary on training and education in medical statistics, in celebration of 40 years of statistics in medicine and 50 years of the MSc medical statistics at LSHTM

Deborah Ashby

摘要

Forty years ago, I was an MSc Medical Statistics student at LSHTM, and a very new member of the Royal Statistical Society. In 1981, in the medical world, cases of a new disease, later termed AIDS, were being talked about and the HIV virus was as yet unknown. Meanwhile, in my world, I learned about classical statistical inference with brief mention of something called Bayes, epidemiological study designs, and analytical techniques, with statistical analyses done by typing code line by line on to punchcards, which were then deposited to be run, with the output available for collection some while later. Reading a journal article meant going to a library and getting a heavy tome out onto a desk. And a new journal to be called Statistics in Medicine was being planned. For me, my time as am MSc student was the beginning of long associations with LSHTM, the Royal Statistical Society, and Statistics in Medicine. I attended Royal Statistical Society meetings, often conveniently held at LSHTM in those days. I got involved in the Medical Section Committee, was elected to Council, and most recently have had the great honor to serve as President. When the Medical Section ran a joint meeting with London School of Economics on Methodological and Ethical Issues in Clinical Trials featuring the classical/Bayes debate inter alia I edited a Special Issue of Statistics in Medicine to publish those proceedings.1 It was the first time I met Don Berry, who along with David Spiegelhalter, had a profound influence on my thinking as to the role of Bayes in trials, although at that stage it was not yet happening in real time. I have subsequently published a number of papers in Statistics in Medicine on aspects of Bayesian trials, including a tutorial on Bayesian data monitoring2 and was invited to review Bayesian Statistics in Medicine for the 25th anniversary volume.3 At LSHTM I initially visited for collaborations when my PhD supervisor Stuart Pocock, had moved there, and later was invited back to teach Bayesian inference on the MSc for several years running—a lovely illustration of how the MSc prepared me to think and be open to new ideas, which I was then able to take back to challenge future generations of students. In those intervening years, the world has changed—we can now do large, complex analyses using small portable devices, using numerical simulation techniques which have revolutionized the ways we can use Bayesian approaches. Those same devices can access any journal article instantaneously and enable meetings with people the other side of the globe. The HIV virus was identified in 19834 paving the way for treatments to be developed to transform it from a fatal disease into a disease with which one lives. Trials and other studies have played a pivotal role, and those trials have influenced the way we do research, although we do not yet, 40 years on, have a vaccine. HIV was not mentioned on my MSc, but the education prepared statisticians to be able to step up to the challenge. I titled my Royal Statistical Society Presidential Address “Pigeonholes and mustard seeds: growing capacity to use data for society” with a key theme being how we develop people with the skills needed at the scale needed for today's challenges.5 The mustard seeds refer to Florence Nightingale's quote “I never lose an opportunity of urging a practical beginning, however small, for it is wonderful how often in such matters the mustard-seed germinates and roots itself” and as an example I cited Peter Armitage foresight in setting up the MSc in Medical Statistics at LSHTM. There were just five students in the first cohort, and I was later taught by one of those, Richard Hayes, so they were indeed the mustard seeds for subsequent cohorts which now number many hundreds, if not thousands, in all corners of the globe. In my Presidential Address, I talked about both the greater depth of training needed for some individuals, as well as a hugely greater increase in the numbers of people needed, from those in the traditional statistical and mathematical moulds as well as data scientists and those who use need to use data science skills intelligently as a part of their work. I said that those who work in AI and ML need to understand statistical principles, but it is equally important that statisticians should learn more about AI and ML, both for their own sakes, and to be able to engage with those communities. I also said that part of the solution is more flexible models of education and training. As well as traditional campus-based courses, there is an explosion in on-line learning, ranging from individual massive open on-line courses, which are often available free or at minimal costs, to full Master's courses, which are well suited to areas such as ours. I also predicted that, for some, these will replace traditional campus-based study, but for others they can be a source of accessible continuing professional development. Finally, I said that different people may need different levels of various aspects at different career stages, but it should also be possible to transition between them when needed. That can have profound implications for how we think about education and training. Personally, I think of statistics as a language for communicating what we can learn from data. I suggested that the Common European Framework of Reference for Languages,6 may be a helpful analogy in planning training and continuing professional development for individuals and groups. Explicitly learning how to work in “team mode” is also a priority, with communication being a critical skill. On communication, the Royal Statistical Society has also had a number of initiatives to offer training and to work in other ways with journalists and politicians to increase the quality of statistical discourse in society. Although that may still be at the mustard seed stage, I trust those mustard seeds will germinate. Today, in 2021, MSc students are studying in extraordinary circumstances due to COVID-19, and on-line learning has evolved faster than any of us could have predicted in 2019. But on the bright side, what took 40 years with HIV has been achieved in a small fraction of that time for COVID-19, from the identification of the pathogen SARS-COV-2 and a growing understanding of the epidemiology, to the setting up of platform trials for testing of treatments and the development and rollout of vaccines within a year. I have never considered myself primarily an infectious disease researcher, but like many others, have had to learn fast. So I find myself involved in the REACT studies monitoring the prevalence of the virus in England,7, 8 which combines design principles I learnt at LSHTM with modern analyses to exploit the temporal and spatial structure of the data. I also play a role as chair of the DSMC for the PRINCIPLE trial, an adaptive platform trial to look at treatments for patients with COVID-19 in the community (https://www.principletrial.org), which uses Bayesian design and analysis to make most efficient use of the data. Coming full circle, Berry Consultants, founded by Don Berry with Scott Berry to meet the growing demand for Bayesian approaches in trials, are partners in this. Both REACT and PRINCIPLE are large-scale initiatives and were set up in a tiny fraction of the time it normally takes to get research projects underway. The pace of these and similar projects is an extraordinary testament to science and scientists, including statisticians- and to those who trained those scientists and statisticians. Prosecuting researching in a novel area at this pace relies on really firm foundations. Many of today's students will spend careers working though the short and long-term consequences of COVID-19 on health, and other health problems have not gone away. And who knows what else may emerge to challenge us. May LSTHM and other institutions continue to educate and train the future generations of statisticians, and Statistics in Medicine continue to publish the fruits of those labors and contribute to further understanding and development of statistics that will improve the health of populations everywhere. *(abstract via OpenAlex)*

SiM Diagnostics & Prediction Longitudinal Data Bayesian Methods · 发表于 2022-02-23

A multivariate parametric empirical Bayes screening approach for early detection of hepatocellular carcinoma using multiple longitudinal biomarkers

Nabihah Tayob, Anna S. F. Lok, Ziding Feng

摘要

The early detection of hepatocellular carcinoma (HCC) is critical to improving outcomes since advanced HCC has limited treatment options. Current guidelines recommend HCC ultrasound surveillance every 6 months in high‐risk patients however the sensitivity for detecting early stage HCC in clinical practice is poor. Blood‐based biomarkers are a promising direction since they are more easily standardized and less resource intensive. Combining of multiple biomarkers is more likely to achieve the sensitivity required for a clinically useful screening algorithm and the longitudinal trajectory of biomarkers contains valuable information that should be utilized. We propose a multivariate parametric empirical Bayes (mPEB) screening approach that defines personalized thresholds for each patient at each screening visit to identify significant deviations that trigger additional testing with more sensitive imaging. The Hepatitis C Antiviral Long‐term Treatment against Cirrhosis (HALT‐C) trial provides a valuable source of data to study HCC screening algorithms. We study the performance of the mPEB algorithm applied to serum ‐fetoprotein, a widely used HCC surveillance biomarker, and des‐ carboxy prothrombin, an HCC risk biomarker that is FDA approved but not used in practice in the United States. Using cross‐validation, we found that the mPEB algorithm demonstrated moderate but improved sensitivity compared to alternative screening approaches. Future research will validate the clinical utility of the approach in larger cohort studies with additional biomarkers.

Biometrics High-Dimensional · 发表于 2022-02-22

Screening Methods for Linear Errors-in-Variables Models in High Dimensions

Linh H. Nghiem, Francis K.C. Hui, Samuel Müller, A.H. Welsh

摘要

Microarray studies, in order to identify genes associated with an outcome of interest, usually produce noisy measurements for a large number of gene expression features from a small number of subjects. One common approach to analyzing such high-dimensional data is to use linear errors-in-variables (EIV) models; however, current methods for fitting such models are computationally expensive. In this paper, we present two efficient screening procedures, namely, corrected penalized marginal screening (PMSc) and corrected sure independence screening (SISc), to reduce the number of variables for final model building. Both screening procedures are based on fitting corrected marginal regression models relating the outcome to each contaminated covariate separately, which can be computed efficiently even with a large number of features. Under mild conditions, we show that these procedures achieve screening consistency and reduce the number of features substantially, even when the number of covariates grows exponentially with sample size. In addition, if the true covariates are weakly correlated, we show that PMSc can achieve full variable selection consistency. Through a simulation study and an analysis of gene expression data for bone mineral density of Norwegian women, we demonstrate that the two new screening procedures make estimation of linear EIV models computationally scalable in high-dimensional settings, and improve finite sample estimation and selection performance compared with estimators that do not employ a screening stage.

Biometrics Bayesian Methods Latent Variables & Mixtures Nonparametric & Semiparametric · 发表于 2022-02-22

Bayesian Nonparametric Analysis for the Detection of Spikes in Noisy Calcium Imaging Data

Laura D'Angelo, Antonio Canale, Zhaoxia Yu, Michele Guindani

摘要

Recent advancements in miniaturized fluorescence microscopy have made it possible to investigate neuronal responses to external stimuli in awake behaving animals through the analysis of intracellular calcium signals. An ongoing challenge is deconvolving the temporal signals to extract the spike trains from the noisy calcium signals' time series. In this article, we propose a nested Bayesian finite mixture specification that allows the estimation of spiking activity and, simultaneously, reconstructing the distributions of the calcium transient spikes' amplitudes under different experimental conditions. The proposed model leverages two nested layers of random discrete mixture priors to borrow information between experiments and discover similarities in the distributional patterns of neuronal responses to different stimuli. Furthermore, the spikes' intensity values are also clustered within and between experimental conditions to determine the existence of common (recurring) response amplitudes. Simulation studies and the analysis of a dataset from the Allen Brain Observatory show the effectiveness of the method in clustering and detecting neuronal activities.

SMMR Clinical Trials Diagnostics & Prediction Bayesian Methods · 发表于 2022-02-22

A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapy

Beibei Guo, Yong Zang

摘要

Immunotherapy is an innovative treatment that enlists the patient’s immune system to battle tumors. The optimal dose for treating patients with an immunotherapeutic agent may differ according to their biomarker status. In this article, we propose a biomarker-based phase I/II dose-finding design for identifying subgroup-specific optimal dose for immunotherapy (BSOI) that jointly models the immune response, toxicity, and efficacy outcomes. We propose parsimonious yet flexible models to borrow information across different types of outcomes and subgroups. We quantify the desirability of the dose using a utility function and adopt a two-stage dose-finding algorithm to find the optimal dose for each subgroup. Simulation studies show that the BSOI design has desirable operating characteristics in selecting the subgroup-specific optimal doses and allocating patients to those optimal doses, and outperforms conventional designs.

SiM Bayesian Methods · 发表于 2022-02-22

A Bayesian hierarchical model for individual participant data meta‐analysis of demand curves

Shengwei Zhang, Haitao Chu, Warren K. Bickel, Chap T. Le, Tracy T. Smith, Janet L. Thomas, Eric C. Donny, Dorothy K. Hatsukami, Xianghua Luo

摘要

Individual participant data meta‐analysis is a frequently used method to combine and contrast data from multiple independent studies. Bayesian hierarchical models are increasingly used to appropriately take into account potential heterogeneity between studies. In this paper, we propose a Bayesian hierarchical model for individual participant data generated from the Cigarette Purchase Task (CPT). Data from the CPT details how demand for cigarettes varies as a function of price, which is usually described as an exponential demand curve. As opposed to the conventional random‐effects meta‐analysis methods, Bayesian hierarchical models are able to estimate both the study‐specific and population‐level parameters simultaneously without relying on the normality assumptions. We applied the proposed model to a meta‐analysis with baseline CPT data from six studies and compared the results from the proposed model and a two‐step conventional random‐effects meta‐analysis approach. We conducted extensive simulation studies to investigate the performance of the proposed approach and discussed the benefits of using the Bayesian hierarchical model for individual participant data meta‐analysis of demand curves.

Biometrika Clinical Trials Testing & Uncertainty Nonparametric & Semiparametric · 发表于 2022-02-21

Multi-scale Fisher’s independence test for multivariate dependence

S Gorsky, L Ma

摘要

Summary: Identifying dependency in multivariate data is a common inference task that arises in numerous applications. However, existing nonparametric independence tests typically require computation that scales at least quadratically with the sample size, making it difficult to apply them in the presence of massive sample sizes. Moreover, resampling is usually necessary to evaluate the statistical significance of the resulting test statistics at finite sample sizes, further worsening the computational burden. We introduce a scalable, resampling-free approach to testing the independence between two random vectors by breaking down the task into simple univariate tests of independence on a collection of $2\times 2$ contingency tables constructed through sequential coarse-to-fine discretization of the sample , transforming the inference task into a multiple testing problem that can be completed with almost linear complexity with respect to the sample size. To address increasing dimensionality, we introduce a coarse-to-fine sequential adaptive procedure that exploits the spatial features of dependency structures. We derive a finite-sample theory that guarantees the inferential validity of our adaptive procedure at any given sample size. We show that our approach can achieve strong control of the level of the testing procedure at any sample size without resampling or asymptotic approximation and establish its large-sample consistency. We demonstrate through an extensive simulation study its substantial computational advantage in comparison to existing approaches while achieving robust statistical power under various dependency scenarios, and illustrate how its divide-and-conquer nature can be exploited to not just test independence, but to learn the nature of the underlying dependency. Finally, we demonstrate the use of our method through analysing a dataset from a flow cytometry experiment.

JRSSB Other 讨论 / 评论 · 发表于 2022-02-21

J. Goseling and M.N.M. van Lieshout's Contribution to the Discussion of ‘Gaussian Differential Privacy’ by Donget al

J. Goseling, M.N.M. van Lieshout

摘要

We congratulate Professors Dong, Roth and Su on their compelling work on Gaussian Differential Privacy. In official statistics, the p%-rule (Hundepoel et al., 2012) is widely used to protect tabular data. In recent work (Hut et al., 2020) we adapted this concept to thematic maps, for example, of energy consumption per company. Usually such maps are drawn directly from an underlying table that is protected from disclosure. The resulting colour-coded map, however, is, by construction, discretised in regions defined by the cells in the table. These geographic regions are usually large, corresponding, for instance, to municipalities. The resulting protection is very conservative, leading to a map with reduced utility. Therefore, there is a need for smooth thematic maps. One might use the Nadaraya–Watson kernel weighted average. This procedure, however, is not necessarily safe. Indeed, suppose that an attacker is able to read off the plotted, smoothed, values of the variables of interest at all measurement locations. Then their original values satisfy a linear system which in many cases (including that of a Gaussian kernel) can be solved exactly if the measurement locations are distinct. *(abstract via OpenAlex)*

JRSSB Testing & Uncertainty · 发表于 2022-02-21

Gaussian Differential Privacy

Jinshuo Dong, Aaron Roth, Weijie J. Su

摘要

In the past decade, differential privacy has seen remarkable success as a rigorous and practical formalization of data privacy. This privacy definition and its divergence based relaxations, however, have several acknowledged weaknesses, either in handling composition of private algorithms or in analysing important primitives like privacy amplification by subsampling. Inspired by the hypothesis testing formulation of privacy, this paper proposes a new relaxation of differential privacy, which we term ‘f-differential privacy’ (f-DP). This notion of privacy has a number of appealing properties and, in particular, avoids difficulties associated with divergence based relaxations. First, f-DP faithfully preserves the hypothesis testing interpretation of differential privacy, thereby making the privacy guarantees easily interpretable. In addition, f-DP allows for lossless reasoning about composition in an algebraic fashion. Moreover, we provide a powerful technique to import existing results proven for the original differential privacy definition to f-DP and, as an application of this technique, obtain a simple and easy-to-interpret theorem of privacy amplification by subsampling for f-DP. In addition to the above findings, we introduce a canonical single-parameter family of privacy notions within the f-DP class that is referred to as ‘Gaussian differential privacy’ (GDP), defined based on hypothesis testing of two shifted Gaussian distributions. GDP is the focal privacy definition among the family of f-DP guarantees due to a central limit theorem for differential privacy that we prove. More precisely, the privacy guarantees of any hypothesis testing based definition of privacy (including the original differential privacy definition) converges to GDP in the limit under composition. We also prove a Berry–Esseen style version of the central limit theorem, which gives a computationally inexpensive tool for tractably analysing the exact composition of private algorithms. Taken together, this collection of attractive properties render f-DP a mathematically coherent, analytically tractable and versatile framework for private data analysis. Finally, we demonstrate the use of the tools we develop by giving an improved analysis of the privacy guarantees of noisy stochastic gradient descent.

Biometrics Longitudinal Data Functional Data High-Dimensional · 发表于 2022-02-21

Functional Data Analysis for Longitudinal Data with Informative Observation Times

Caleb Weaver, Luo Xiao, Wenbin Lu

摘要

In functional data analysis for longitudinal data, the observation process is typically assumed to be noninformative, which is often violated in real applications. Thus, methods that fail to account for the dependence between observation times and longitudinal outcomes may result in biased estimation. For longitudinal data with informative observation times, we find that under a general class of shared random effect models, a commonly used functional data method may lead to inconsistent model estimation while another functional data method results in consistent and even rate-optimal estimation. Indeed, we show that the mean function can be estimated appropriately via penalized splines and that the covariance function can be estimated appropriately via penalized tensor-product splines, both with specific choices of parameters. For the proposed method, theoretical results are provided, and simulation studies and a real data analysis are conducted to demonstrate its performance.

SiM Causal Inference Clinical Trials · 发表于 2022-02-21

Estimation of the proportion of treatment effect explained by a high‐dimensional surrogate

Ruixuan Rachel Zhou, Sihai Dave Zhao, Layla Parast

摘要

Clinical studies examining the effectiveness of a treatment with respect to some primary outcome often require long‐term follow‐up of patients and/or costly or burdensome measurements of the primary outcome of interest. Identifying a surrogate marker for the primary outcome of interest may allow one to evaluate a treatment effect with less follow‐up time, less cost, or less burden. While much clinical and statistical work has focused on identifying and validating surrogate markers, available approaches tend to focus on settings in which only a single surrogate marker is of interest. Limited work has been done to accommodate the high‐dimensional surrogate marker setting where the number of potential surrogates is greater than the sample size. In this article, we develop methods to estimate the proportion of treatment effect explained by high‐dimensional surrogates. We study the asymptotic properties of our proposed estimator, propose inference procedures, and examine finite sample performance via a simulation study. We illustrate our proposed methods using data from a randomized study comparing a novel whey‐based oral nutrition supplement with a standard supplement with respect to change in body fat percentage over 12 weeks, where the surrogate markers of interest are gene expression probesets.

Biometrics Bayesian Methods · 发表于 2022-02-21

A Hierarchical Model for Analyzing Multisite Individual-Level Disease Surveillance Data from Multiple Systems

Yuzi Zhang, Howard H. Chang, Qu Cheng, Philip A. Collender, Ting Li, Jinge He, Justin V. Remais

摘要

Passive surveillance systems are widely used to monitor diseases occurrence over wide spatial areas due to their cost-effectiveness and integration into broadly distributed healthcare systems. However, such systems are generally associated with imperfect ascertainment of disease cases and with heterogeneous capture probabilities arising from factors such as differential access to care. Augmenting passive surveillance systems with other surveillance efforts provides a way to estimate the true number of incident cases. We develop a hierarchical modeling framework for analyzing data from multiple surveillance systems that allows for individual-level covariate-dependent heterogeneous capture probabilities, and borrows information across surveillance sites to improve estimation of the true number of incident cases. Inference is carried out via a two-stage Bayesian procedure. Simulation studies illustrated superior performance of the proposed approach with respect to bias, root mean square error, and coverage compared to a model that does not borrow information across sites. We applied the proposed model to data from three surveillance systems reporting pulmonary tuberculosis (PTB) cases in a major center of ongoing transmission in China. The analysis yielded bias-corrected estimates of PTB cases from the passive system and led to the identification of risk factors associated with PTB rates, as well as factors influencing the operating characteristics of the implemented surveillance systems.

SiM Machine Learning Functional Data · 发表于 2022-02-20

Pooling random forest and functional data analysis for biomedical signals supervised classification: Theory and application to electrocardiogram data

Fabrizio Maturo, Rosanna Verde

摘要

Scientific progress has contributed to creating many devices to gather vast amounts of biomedical data over time. The goal of these devices is generally to monitor people's health conditions, diagnose, and prevent patients' diseases, for example, to discover cardiovascular disorders or predict epileptic seizures. A common way of investigating these data is classification, but these instruments generate signals often characterized by high dimensionality. Learning from these data is definitely a challenging task due to many issues, for example, the trade‐off between complexity and accuracy and the course of dimensionality. This study proposes a supervised classification method based on the joint use of functional data analysis, classification trees, and random forest to deal with massive biomedical data recorded over time. For this purpose, this research suggests different original tools to extract features and train functional classifiers, interpret the classification rules, assess leaves' quality and composition, avoid the classical drawbacks due to the COD, and improve the accuracy of the functional classifiers. Focusing on ECG data as a possible example, the final purpose of this study is to offer an original approach to identify and classify patients at risk using different types of biomedical signals. The results confirm that this line of research is exciting; indeed, the interpretative tools show evidence to be very useful for understanding classification rules. Furthermore, the performance of the proposed functional classifier, in terms of accuracy, is excellent because the latter breaks the previous classification record regarding a well‐known ECG dataset.

SiM Causal Inference Clinical Trials · 发表于 2022-02-20

Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison design

Xiaoyan Liu, Chanmin Kim, Zifei Han, Pilar Lim, Satrajit Roychoudhury, Maurizio Fava, Gheorghe Doros

摘要

In clinical trials, placebo response is considered a beneficial effect arising from multiple factors, including the patient's expectations for the treatment. Its presence makes the classical parallel study design suboptimal and can bias the inference. The sequential parallel comparison design (SPCD), a two‐stage design where the first stage is a classical parallel study design, followed by another parallel design among placebo subjects from the first stage, was proposed to address the shortcomings of the classical design. In SPCD, in lieu of treatment effect, a weighted average of the mean treatment difference in Stage I among all randomized subjects and the mean treatment difference in Stage II among placebo non‐responders was proposed as the efficacy measure. However, by linking two possibly different populations, this weighted average lacks interpretability, and the choice of weight remains controversial. In this work, under the principal stratification framework, we propose a causal estimand for the treatment effect under each of three clinically important principal strata: Always Responders, Never Responders, and Drug‐only Responders. To make the stratum treatment effect identifiable, we introduce a set of assumptions and two sensitivity parameters. By further considering the strata as latent characteristics, the sensitivity parameters can be estimated. An extensive simulation study is conducted to evaluate the operating characteristics of the proposed method. Finally, we apply our method on the ADAPT‐A study data to assess the benefit of low‐dose aripiprazole adjunctive to antidepressant therapy treatment.

Biometrics Genetics & Omics Networks & Graphs High-Dimensional · 发表于 2022-02-19

Joint Gene Network Construction by Single-Cell RNA Sequencing Data

Meichen Dong, Yiping He, Yuchao Jiang, Fei Zou

摘要

In contrast to differential gene expression analysis at the single-gene level, gene regulatory network (GRN) analysis depicts complex transcriptomic interactions among genes for better understandings of underlying genetic architectures of human diseases and traits. Recent advances in single-cell RNA sequencing (scRNA-seq) allow constructing GRNs at a much finer resolution than bulk RNA-seq and microarray data. However, scRNA-seq data are inherently sparse, which hinders the direct application of the popular Gaussian graphical models (GGMs). Furthermore, most existing approaches for constructing GRNs with scRNA-seq data only consider gene networks under one condition. To better understand GRNs across different but related conditions at single-cell resolution, we propose to construct Joint Gene Networks with scRNA-seq data (JGNsc) under the GGMs framework. To facilitate the use of GGMs, JGNsc first proposes a hybrid imputation procedure that combines a Bayesian zero-inflated Poisson model with an iterative low-rank matrix completion step to efficiently impute zero-inflated counts resulted from technical artifacts. JGNsc then transforms the imputed data via a nonparanormal transformation, based on which joint GGMs are constructed. We demonstrate JGNsc and assess its performance using synthetic data. The application of JGNsc on two cancer clinical studies of medulloblastoma and glioblastoma gains novel insights in addition to confirming well-known biological results.

Biometrics Testing & Uncertainty · 发表于 2022-02-18

The Generalized Fisher's Combination and AccurateP-Value Calculation under Dependence

Hong Zhang, Zheyang Wu

摘要

Combining dependent tests of significance has broad applications but the related p-value calculation is challenging. For Fisher's combination test, current p-value calculation methods (eg, Brown's approximation) tend to inflate the type I error rate when the desired significance level is substantially less than 0.05. The problem could lead to significant false discoveries in big data analyses. This paper provides two main contributions. First, it presents a general family of Fisher type statistics, referred to as the GFisher, which covers many classic statistics, such as Fisher's combination, Good's statistic, Lancaster's statistic, weighted Z-score combination, and so forth. The GFisher allows a flexible weighting scheme, as well as an omnibus procedure that automatically adapts proper weights and the statistic-defining parameters to a given data. Second, the paper presents several new p-value calculation methods based on two novel ideas: moment-ratio matching and joint-distribution surrogating. Systematic simulations show that the new calculation methods are more accurate under multivariate Gaussian, and more robust under the generalized linear model and the multivariate t-distribution. The applications of the GFisher and the new p-value calculation methods are demonstrated by a gene-based single nucleotide polymorphism (SNP)-set association study. Relevant computation has been implemented to an R package GFisher available on the Comprehensive R Archive Network.

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 页